Data as of 4:02pm ET
| -0.45 / -1.35%|
The 28 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 37.29, with a high estimate of 42.57 and a low estimate of 26.78. The median estimate represents a +13.52% increase from the last price of 32.85.
The current consensus among 34 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.